These findings, along with no known history of CML, absence of splenomegaly, and lack of basophilia, supported the diagnosis of AML with BCR:ABL fusion by WHO5 classification (Table 1 and Figs 1D and 1E). This evidence concerns the gene ABL1 and acute myeloid leukemia.